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Abstract
Background: The aetiology of urological cancers is poorly understood and variations in incidence by ethnic group
may provide insights into the relative importance of genetic and environmental risk factors. Our objective was to
compare the incidence of four urological cancers (kidney, bladder, prostate and testicular) among six ‘non-White’
ethnic groups in England (Indian, Pakistani, Bangladeshi, Black African, Black Caribbean and Chinese) to each other
and to Whites.
Methods: We obtained Information on ethnicity for all urological cancer registrations from 2001 to 2007 (n = 329,524)
by linkage to the Hospital Episodes Statistics database. We calculated incidence rate ratios adjusted for age, sex and
income, comparing the six ethnic groups (and combined ‘South Asian’ and ‘Black’ groups) to Whites and to each
other.
Results: There were significant differences in the incidence of all four cancers between the ethnic groups (all p <
0.001). In general, ‘non-White’ groups had a lower incidence of urological cancers compared to Whites, except prostate
cancer, which displayed a higher incidence in Blacks. (IRR 2.55) There was strong evidence of differences in risk
between Indians, Pakistanis and Bangladeshis for kidney, bladder and prostate cancer (p < 0.001), and between Black
Africans and Black Caribbeans for all four cancers (p < 0.001).
Conclusions: The risk of urological cancers in England varies greatly by ethnicity, including within groups that have
traditionally been analysed together (South Asians and Blacks). In general, these differences are not readily explained by
known risk factors, although the very high incidence of prostate cancer in both black Africans and Caribbeans suggests
increased genetic susceptibility. g.
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Background
Urological cancers account for about 14 % of cancers di-
agnosed globally and more than a fifth of all cancers in
Europe [1]. There is also significant international vari-
ation in incidence and the aetiology of urological cancers
remains poorly understood. Identifying the extent of eth-
nic variation can contribute to our understanding of
aetiology and assist in planning care for different ethnic
groups. Unfortunately international comparisons are of
limited value as registration systems vary in their quality;
there are systematic variations between health systems
and systematic biases exist in the way different popula-
tions access care [2].
The UK is a multi-ethnic society, with ‘non-White’
ethnic groups making up around 14 % of England's
population in 2011. British (South) Asians - Indians,
Pakistanis and Bangladeshis—form the largest group of
about 6 %, and British Blacks - Black Africans (mainly
from Nigeria, South Africa, Ghana and Somalia) and
Black Caribbeans (predominantly from Jamaica)—are
second at about 3 %, with Chinese (mainly from Hong
Kong) about 1 % [3]. Studies have shown South Asians in
the U.S. to have lower rates of kidney, bladder, prostate
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and testicular cancer than Whites and Blacks [4]. South
Asians, however, are a heterogeneous group with varied
socio-cultural practices and the risk of urological cancers
within each individual ethnic group is unknown. Further,
these data do not consider socioeconomic status, and are
therefore subject to under-reporting in ethnic groups with
decreased access to care [5].
Although it has long been known that there are differ-
ences in the incidence of many cancers by ethnic group
[6] and in access to healthcare (including screening) due
to socioeconomic disadvantages [7], studies of cancer in-
cidence in ethnic groups in the UK have been of limited
accuracy in the past due to the incomplete ethnicity data
held by cancer registries. Various techniques have been
used to try and overcome this problem, including using
country of birth, the calculation of proportional inci-
dence ratios and assigning ethnicity on the basis of name
[8–10]. However, all these methods have significant limi-
tations and the most accurate method is to use self–
assigned ethnicity (as has been done in the census since
1991) which allows us to use the same method of assign-
ing ethnicity in the numerator and denominator.
From 1995, self-assigned ethnicity has been recorded
in the National Health System’s Hospital Episodes Statis-
tics (HES) database, and HES records can now be linked
to cancer registrations, providing more reliable informa-
tion on ethnicity [11]. Although the recording of routine
ethnicity data in primary care is still limited [12], hos-
pital data is much better and has improved markedly in
the last 20 years, with the percentage of missing ethni-
city values falling from 35 % in 1998 to less than 10 %
by 2009 [13]. In England, consistency of diagnostic
methods, reporting and registration procedures across
the entire health system removes significant biases in-
trinsic to databases in many other countries.
Our objective was to compare the incidence of kidney,
bladder, prostate and testicular cancer amongst ethnic
groups (Indian, Pakistani, Bangladeshi, Black African,
Black Caribbean and Chinese) in England, to each other
and to Whites.
Methods
The methods used in this study were broadly the same
as those described in our previous studies [14–16] and
are summarized below.
Data collection
Data were obtained from the National Cancer Intelligence
Network (NCIN) for all cancer registrations from January
2001 to December 2007 in England: cancer site coded to
the International Classifications of Diseases, 10th Revision
(ICD-10) [17]; morphology coded to the International
Classifications of Diseases of Oncology, 2nd and 3rd Revi-
sions (ICD-O-2 and ICD-O-3) [18, 19]; deprivation
assessed from the income domain of the Index of Multiple
Deprivation 2007 (IMD 2007) [20]; age at diagnosis of
cancer; sex and ethnicity. To determine population inci-
dence data, mid-year population estimates produced by
the Office of National Statistics (ONS) from 2001 to 2007
were used, stratified by age, sex and ethnicity. Population
data stratified by national quintiles of the income domain
were provided by ONS based on the 2001 census and the
same distributions applied to population data by age, sex
and ethnicity for the 2001-2007 mid-year population
estimates.
Classification of ethnicity
NCIN obtained the self-assigned ethnicity for each can-
cer registration by record linkage to the Hospital Epi-
sodes Statistics (HES) database. If a cancer registration
could not be linked to HES, or if ethnicity data were
missing on the HES database, then ethnicity was
assigned using information recorded in the cancer regis-
try data. Prior to April 2001, ethnicity was coded both
by HES and by cancer registries using the classification
system of the 1991 Census. After April 2001, the codes
were amended to those of the 2001 Census, although
1991 ethnicity codes were accepted until 2003. For these
analyses, we classified ethnicity as White (White from
the 1991 Census and White British from the 2001 Cen-
sus), Indian, Pakistani and Bangladeshi, (with the three
groups combined to form the category ‘South Asian’),
Black African, Black Caribbean (again both combined to
form the category, ‘Black’) and Chinese. (Sri Lankans are
not recorded as a separate ethnic group in the census or
HES data and so are not included in our analysis.)
Classification of cancers
Cancers were classified as cancers of the prostate (ICD-
10 code C61), testes (C62), kidney (C64, C65, C66 and
C68) and bladder (C67).
Statistical analyses
We estimated age standardised rates (ASRs) of each can-
cer per 100,000 person-years for all ethnic groups using
direct standardisation to the 1960 Segi world population
[21], with age at diagnosis of cancer being classified into
6 categories: <40, 40–49, 50–59, 60–69, 70–79, and ≥ 80
years. We used Poisson regression to estimate incidence
rate ratios (IRRs) comparing each ethnic group, and the
two combined categories of South Asian and Black, to
Whites adjusting for age, sex (where appropriate) and
deprivation.
When comparing South Asians and Blacks to Whites,
we present results as RRs and 99 % confidence intervals
(CIs). When comparing the individual ethnic groups, re-
sults are presented as IRRs and 99 % floating confidence
intervals (FCIs). FCIs were calculated using the method
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of floating absolute risks [22] and enable valid compari-
sons between any two ethnic groups, even if neither one
is the baseline. We calculated 99 % CIs because of mul-
tiple tests performed across ethnic groups.
We performed pre-specified subgroup analyses by sex,
where appropriate, and by tumor type, which were
grouped according to morphology. Specifically cancers
of the prostate were grouped as adenocarcinoma
(ICD-O-3 codes 8140, 8141 8143, 8147, 8211, 8251,
8255, 8260–82633, 8310, 8480, 8481, 8503, 8570–8574)
and other tumors; cancer of the testes as seminoma
(9060–9062, 9064) and non-seminomatous (9065–9102);
cancer of the kidney as renal cell carcinoma (8050, 8140,
8260, 8270, 8280–8312, 8316–8320, 8340–8344) and
other; and cancer of the bladder as transitional
(8050,8120–8122,8130–8131) and other. We also did a
pre-specified subgroup analysis by age for prostate cancer,
with cases divided into those aged under 50 and those
aged 50 or above. We did not analyse the other cancers by
age as case numbers were too low.
Tests of heterogeneity of IRRs between ethnicities, ei-
ther overall or restricted to South Asians or Blacks, were
performed using likelihood χ2 ratio tests. The test of het-
erogeneity of RRs between pre-specified subgroups was
performed for South Asians, Blacks and Chinese using a
χ2 contrast test.
Sensitivity analysis
Because ethnicity information was not complete for all
registered cancers, we used multiple imputations to as-
sess the effect the missing values of ethnicity had on our
results. We generated 40 datasets with imputed values of
ethnicity using a multinomial logistic regression model
where the predictor variables were age, deprivation (in-
come) and site of cancer. We performed our primary
analysis examining the effect of ethnicity on cancer for
each dataset. The resulting IRRs were combined using
Rubin’s combination rules [23].
We performed all analyses using Stata V.12 and R stat-
istical software packages.
Graphical presentation of results
Where results are presented in the form of plots, we
represent IRRs for each ethnic group by squares and
their corresponding 99 % FCIs by straight lines. For the
combined ‘South Asian’ and ‘Black’ group, we show IRRs
as open diamonds, whose horizontal extent indicates the
99 % CI. We placed a dashed vertical line at the value of
the IRRs for all South Asians and for all Blacks.
Comparison to rates in countries of origin
We also compared the ASRs for each ethnic group in
England to rates from their country or region of origin
using data from the GLOBOCAN database [1]. For
Blacks, we used GLOBOCAN estimates for Sub-Saharan
Africa and the Caribbean; there are no population based
cancer registries in their main countries of origin.
This study was approved by the Oxford Research Eth-
ics Committee.
Results
Table 1 shows socio-demographic information from the
2001 census for Whites, Indians, Pakistanis, Banglade-
shis, Black Africans, Black Caribbeans and Chinese. All
six groups are, on average, younger than Whites and all
except Chinese are also poorer, with Pakistanis, Bangla-
deshis and Black Africans being the most deprived.
Table 2 shows the number of cancer registrations by
ethnic group, and missing ethnicity values for each can-
cer. In total there were 329,524 urological cancer regis-
trations and ethnicity information was missing in 81,767
(24.8 %) cases.
Figure 1 shows the overall age-standardised incidence
rates and rate ratios, adjusted by age, sex and income,
for the four urological cancers by individual ethnic
group compared to Whites. For all four cancers,
there is significant heterogeneity between ethnic groups
(p < 0.001), with a lower incidence for all ethnic groups
compared to Whites, for all cancers except prostate can-
cer, where Blacks had by far the highest incidence.
For kidney cancer (Fig. 2), the overall incidence in
Chinese and South Asians was about half that in Whites,
with risk in Indians significantly lower than in Pakistanis
and Bangladeshis. (IRRs of 0.47, 0.67 and 0.66 respect-
ively, P < 0.001). The incidence in Blacks was also lower
than Whites with higher rates in Black Africans than
Black Caribbeans. (IRRs of 0.94 and 0.67 respectively,
P = 0.002). These trends were maintained in subgroup
analyses by tumour type. Across all ethnicities, risk
was higher in men than women but the relative risk
compared to Whites was similar in men and women
for all non-White groups.
For bladder cancer (Fig. 3), the overall incidence in
South Asians and Blacks was nearly two thirds lower
than in Whites with no significant difference between
Indians, Pakistanis and Bangladeshis, or between Black
Africans and Black Caribbeans. The risk in Chinese was
about half that of Whites. These trends were maintained
in subgroup analyses by tumour type. Across all ethnici-
ties, risk was higher in men than women but the relative
risk compared to Whites was similar in men and women
for all non-White groups.
For prostate cancer (Fig. 4), the overall incidence in
South Asians was almost half that in Whites with
substantial differences between Indians, Pakistanis and
Bangladeshis (IRRs of 0.55, 0.64 and 0.33 respectively,
P < 0.001) with Chinese also having a lower incidence
than Whites. The incidence in both Black Caribbeans
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and Black Africans was more than double that of
Whites. These trends were confirmed in subgroup ana-
lyses by both age and tumour type; Black Caribbeans and
Black Africans displayed the highest incidence in both
those aged less than and greater than 50 and in both
adenocarcinoma and ‘other’ types of prostate cancer.
For testicular cancer (Fig. 5), incidence in all ethnic
groups was much lower than in Whites, about a third in
South Asians and Chinese with blacks having the lowest
incidence and lower rates in Black Africans than Black
Caribbeans. These trends were maintained in subgroup
analyses by tumour type and also showed that South
Asians have a higher incidence of non-seminomatous tu-
mours compared to seminomas.
Sensitivity analysis
In the sensitivity analysis which assigned missing values
using multiple imputations, results very similar to those
shown in Fig. 1 were obtained, as shown in Additional
file 1: figure S1 (online).
Comparison to rates in countries of origins
Table 3 compares international data on age standardised
incidence rates from GLOBOCAN. Across all ethnicities,
ASRs for kidney, prostate and testicular cancers were
lower in their countries of origins. Bladder cancer
incidence was higher in respective countries of origins,
than in comparative ethnicities in England. For all eth-
nicities, in both England and countries of origins, the in-
cidence of kidney, bladder, prostate and testicular cancers
was less than in Whites, except for prostate cancer in Ca-
ribbeans which was higher in the Carribean than in
Whites.
Discussion
We compared incidence rates for urological cancers in
the main ‘non-White’ ethnic groups in England – South
Asian (Indian, Pakistani and Bangladeshi), Black (African
and Caribbean) and Chinese to Whites and to each
other. There was considerable variation by ethnic group,
even when age and socioeconomic factors were taken
into account. Overall, urological cancers were diagnosed
less often in all the ‘non-White’ ethnic groups, except
prostate cancer in Blacks, which demonstrated a higher
incidence than in Whites. Amongst South Asians, we
demonstrated that the incidence of urological cancers
substantially differed between Pakistanis, Bangladeshis
and Indians, supporting the notion that South Asians
should not be viewed as a single ethnic group. Similarly,
large differences existed between Black African and
Caribbean populations, highlighting the need to differen-
tiate between these two groups.
Table 1 Comparison of demographic characteristics by ethnic group in England in 2001 using data from the 2001 census
Ethnic group White Indian Pakistani Bangladeshi Black African Black Carribean Chinese
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Census data for 2001
Total population 42,747,136 100 1,028,546 100 706,539 100 275,394 100 475,938 100 561,246 100 220,681 100
Sex Male 20,828,644 48.7 511,204 49.7 358,043 50.7 138,972 50.5 229,103 48.1 259,881 46.3 105,913 48.0
Age <50 27,665,393 64.7 828,200 80.5 625,118 88.5 248,841 90.4 432,985 91.0 426,424 76.0 184,675 83.7
50+ 15,081,743 35.3 200,346 19.5 81,421 11.5 26,553 9.6 42,953 9.0 134,822 24.0 36,006 16.3
Deprivation Low income 7,305,527 17.1 347,098 33.7 455,710 64.5 198,884 72.2 277,858 58.4 292,537 52.1 49,427 22.4
Middle income 26,315,786 61.6 563,939 54.8 222,038 31.4 69,325 25.2 177,234 37.2 245,103 43.7 123,994 56.2
High income 9,125,823 21.3 117,509 11.4 28,791 4.1 7,185 2.6 20,846 4.4 23,606 4.2 47,260 21.4
Country of Birth United Kingdom 41,911,150 98.0 472,545 45.9 387,198 54.8 127,902 46.4 161,050 33.8 324,764 57.9 62,209 28.2
Other 835,986 2.0 556,001 54.1 319,341 45.2 147,492 53.6 314,888 66.2 236,482 42.1 158,472 71.8
Table 2 Distribution of registered cancers from 2001-2007 in England by ethnic group and missing ethnicity values (percentages in
brackets)










Prostate 132278 (62.5) 934 (0.4) 491 (0.2) 90 (0.0) 861 (0.4) 3185 (1.5) 226 (0.1) 10624 (5.0) 63068 (29.8) 211757
Testes 50133 (81.2) 223 (0.4) 117 (0.2) 42 (0.1) 69 (0.1) 186 (0.3) 62 (0.1) 3135 (5.1) 7762 (12.6) 61729
Kidney 7890 (65.7) 88 (0.7) 65 (0.5) 8 (0.1) 17 (0.1) 28 (0.2) 18 (0.2) 831 (6.9) 3064 (25.5) 12009
Bladder 32775 (74.4) 246 (0.6) 170 (0.4) 58 (0.1) 146 (0.3) 239 (0.5) 57 (0.1) 2465 (5.6) 7873 (17.9) 44029
All four cancers 223076 (67.7) 1491 (0.5) 843 (0.3) 198 (0.1) 1093 (0.3) 3638 (1.1) 363 (0.1) 17055 (5.2) 81767 (24.8) 329524
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Fig. 1 Age-standardised incidence rates and rate ratios (adjusted by age, sex and income) for the four urological cancers by individual ethnic
group compared to Whites
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The different patterns of cancer risk between ethnic
groups suggest that our findings are unlikely to be due
to systematic reporting biases in any of the ethnic
groups compared to Whites. Our previous work using
the same dataset showed increased risks of some gastro-
intestinal and haematological cancers in ethnic minority
groups further supporting the absence of an under-
reporting bias [14, 15]. Using self-assigned ethnicity is
Fig. 2 Age-standardised incidence rates and rate ratios (adjusted by age and income) for prostate cancer by ethnic group. Subgroups show rates
and rate ratios subdivided by age and morphology (adenocarcinoma and other)
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also more reliable than other measures of ethnicity (e.g.
name analysis) as it uses the same measure of ethnicity
in the numerator and denominator. We also adjusted for
socioeconomic status, a potential confounder in studies
of health and ethnicity, particularly when comparing
Pakistanis, Bangladeshis and Blacks due to their higher
levels of deprivation [5].
Our findings are consistent with current literature al-
though we are not aware of any previous studies which
present incidence by individual ethnic group for kidney,
bladder and testes cancers. (which grouped all ‘Blacks’
and all ‘South Asians’ together.)
For renal cancer, a previous study showed that South
Asians had a lower incidence of renal cell carcinoma
compared with Whites, consistent with our results [24].
Smoking is a known risk factor for renal cell carcinoma
[25] and our results are consistent with smoking preva-
lence by ethnic group [26]. Some reports have demon-
strated higher incidence of renal cell carcinoma in
African Americans than Whites [27], contrary to our
findings. This discrepancy may be attributable to the fact
that these studies were done in the USA where black
populations may have different countries of origin.
For bladder cancer, previous reports indicate a lower
incidence amongst south Asians [28]. Again, smoking is
a known risk factor for bladder cancer [29] and our re-
sults are consistent with smoking prevalence by ethnic
group with the exception of Chinese [26] who have the
lowest smoking prevalence but the highest bladder can-
cer incidence. This may be due to genetic factors or
other ethnicity-specific risk factors (e.g. dietary soy)
which is frequently used in Chinese cuisine, has been as-
sociated with increased bladder cancer risk [30].
For testicular cancer, previous studies have also re-
vealed a lower incidence amongst Asians and Blacks [31]
consistent with our data. This may be due to inter-
ethnic variations in environmental factors acting pre-
natally or early in childhood [32]. Cryptorchidism, a
Fig. 3 Age-standardised incidence rates and rate ratios (adjusted by age and income) for testicular cancer by ethnic group. Subgroups show
rates and rate ratios subdivided by morphology (seminoma and non-seminomatous)
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known risk factor of testicular cancer, may also vary be-
tween ethnicities, with reports of reduced incidence
amongst black babies [33] but data is not available for
South Asians.
For prostate cancer, studies in the USA have shown
increased incidence in men with African ancestry,
even after migration to areas of lower prevalence [34, 35].
Our finding that Black African and Black Caribbean’s
Fig. 4 Age-standardised incidence rates and rate ratios (adjusted by age, sex and income) for kidney cancer by ethnic group. Subgroups show
rates and rate ratios subdivided by sex and morphology (renal cell cancer & other)
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demonstrated a higher incidence of prostate cancer
than Whites is also consistent with previous UK stud-
ies [28, 31].
The specific cause of increased prostate cancer risk
amongst Blacks is not known. A recent review of
known risk factors for prostate cancer found limited
Fig. 5 Age-standardised incidence rates and rate ratios (adjusted by age, sex and income) for bladder cancer by ethnic group. Subgroups show
rates and rate ratios subdivided by sex and by morphology (transitional cell cancer & other)
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environmental explanation for the racial differences in
incidence [36]. Nonetheless, there have been a num-
ber of dietary factors which have been independently
implicated, including intake of animal fats and prod-
ucts [37]. Increased risk amongst Blacks has also been
attributed to genetic factors including: variants of the
genes of the enzymes involved in androgen biosyn-
thesis and metabolism, such as SRD5A2, CYP17, and
CYP3A4; the C-genotypes CD14; NAT2 and NER
genetic variants; and polymorphisms at 17q21 and
8q24 [38–42]. Although the much higher rates seen
in Black Africans and Caribbean in the UK compared
to their regions of origin is consistent with a change
of environment causing the increase, the very low
rates seen in sub-saharan Africa almost certainly
underestimate the true incidence due to under-
diagnosis and under-reporting. We also note that
rates are generally higher in black populations every-
where—sub-Saharan Africa and the Caribbean, (where
they are almost double compared to other similarly
developed regions) [1], Blacks in the US and Blacks
in the UK. This suggests that the increased risk seen
in Blacks in the UK is most likely due to the change
in environment in genetically susceptible populations.
The role of genetics in determining variation in risk is
reinforced by the observation that both black Africans
and Caribbeans display increased prostate cancer inci-
dence, despite different countries of origin; lifestyles and
environments.
Consistent with our findings, previous reports have
also demonstrated reduced prostate cancer incidence in
Asians compared with Whites [28], and within the
subset of Asians: Indians, Pakistanis and Bangladeshis
[43–47]. The reduced incidence amongst South
Asians has been associated with religion, differences
in diet, reduced vitamin D levels and early-life sun
exposure [48, 49]. Other risk factors associated with
prostate cancer are lack of exercise, antioxidants and
saturated fat, smoking, alcohol consumption, socio-
economic status and carcinogen exposure (e.g. radi-
ation and arsenic) [50–53] and it is possible that
differences in these explain some of the reduced inci-
dence in South Asians. Further, it has been suggested
that South Asians meet with more obstacles when
accessing health care resources, receiving less diag-
nostic and screening (PSA) tests [54]. Within South
Asian ethnic groups, Bangladeshis displayed a sub-
stantially lower incidence of prostate cancer; although
the cause of this is likely multifactorial, obesity has
been linked to prostate cancer [55], and Bangladeshis
show markedly lower obesity prevalence compared to
Indians and Pakistanis [26]. Prostate cancer incidence
in Chinese was higher than in South Asians and this
may in part be contributed to by increased soy, genis-
tein and daidzein intake [56].
The comparison of rates between ethnic groups in
England and their countries of origin is problematic for
a number of reasons. Firstly, population-based cancer
registries simply do not exist in many of these countries,
particularly in the areas from where the majority of mi-
grants originate e.g. Punjab & Gujarat in India, Kashmir
& Punjab in Pakistan, Sylhet in Bangladesh, Jamaica in
the Caribbean and Somalia, Nigeria & Ghana in Africa.
and Even where registries exist the quality is very vari-
able and there are differences in cancer registration
practices [2]. Rates in these developing countries are also
Table 3 Age-standardised incidence rates for urological cancers
by ethnic group in England compared to rates in country of
origin using estimates from Globocan. (sub-Saharan Africa for
Black Africans, Caribbean for Black Caribbeans)
England Incidence from
Globocan
Cancer Site Ethnicity Cases ASR ASR
Prostate White 132278 44.9
Indian 934 23.7 3.7
Pakistani 491 26.2 5.2
Bangladeshi 90 14.0 1.9
Black African 861 99.2 21.2
Black Caribbean 3185 110.1 71.1
Chinese 226 34.6 4.3
Testes White 50133 11.6
Indian 223 6.8 0.6
Pakistani 117 9.5 0.9
Bangladeshi 42 6.3 1.0
Black African 69 8.9 0.4
Black Caribbean 186 6.4 0.7
Chinese 62 9.8 0.4
Kidney White 7890 5.9
Indian 88 3.0 1.1
Pakistani 65 4.3 1.3
Bangladeshi 8 4.2 1.1
Black African 17 5.5 1.1
Black Caribbean 28 4.5 2.7
Chinese 18 3.4 2.8
Bladder White 32775 7.2
Indian 246 2.7 2.8
Pakistani 170 3.2 5.4
Bangladeshi 58 3.7 2.6
Black African 146 3.6 3.7
Black Caribbean 239 3.1 5.8
Chinese 57 3.9 5.5
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likely to be underestimated due to under-diagnosis and
under-ascertainment, and in access to screening and
early detection, particularly for prostate cancer [2]. Mi-
grants are also a selective group and may not be repre-
sentative of the population from which they arose and
they may be more or less healthy than the population in
their native country [6].
Whilst acknowledging these limitations, the increased
incidence of prostate, kidney and testicular cancers in all
ethnic groups in England compared to their countries of
origin is consistent with changes in environmental risk
factors and the differences in screening, diagnosis and
registration. For bladder cancer the picture was more
mixed with higher incidence seen in the countries of ori-
gin of Pakistanis, Black Caribbean and Chinese—the rea-
sons for this are unclear.
The main limitation of our study was that we do
not have individual level information on most expo-
sures. Ethnicity information was missing for 25 % of
cancer registrations—however, this is lower than pre-
vious studies [28, 44] and the sensitivity analysis pro-
duced similar results. Recording of ethnicity in HES
has improved markedly in the last 20 years, with the
percentage of missing ethnicity values falling from 35
% in 1998 to less than 10 % by 2009. The quality of
the ethnic coding in HES has also been assessed and
no ethnic group is widely misrepresented in HES data
for England [13, 14].
Also, the group ‘British White’ inevitably included
some ‘Other (non-British) Whites’ as the ethnic cat-
egory ‘Whites’ included both British Whites and
‘Other Whites’ prior to 2003 although this was less
than 5 % of the ‘total White’ category based on the
data post-2003 so would not materially affect the re-
sults for British Whites. We were therefore also un-
able to compare British Whites to ‘Other Whites’, and
given that the ‘Other White’ population has increased
rapidly since 2004 (due to migration from the Euro-
pean Union), future studies should look at incidence
in this group as well.
Conclusions
This is the first and largest study to investigate the dif-
ferences in incidence of urological cancers by ethnic
group in England. The very high incidence of prostate
cancer in both black Africans and Caribbeans, despite
differing lifestyles and environments and countries of
origin is most likely due to the change in environment
in genetically susceptible populations. The large differ-
ences in incidence we found with other cancers by eth-
nic group are not readily explained by known risk
factors, which suggest that important, potentially modifi-
able, risk factors are yet to be discovered.
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